OS04.5.A A PHASE 2 STUDY OF PEMIGATINIB FOR PRE-TREATED GLIOBLASTOMA OR OTHER GLIOMAS WITH ACTIVATING FGFR1-3 ALTERATIONS: FINAL RESULTS FROM FIGHT-209
OS04.5.AA 培米替尼治疗既往接受过治疗的胶质母细胞瘤或其他伴有FGFR1-3激活改变的胶质瘤的II期研究：FIGHT-209研究的最终结果
期刊:
影响因子:
doi:10.1101/2025.05.28.656647
Chuykin, Ilya; Sokol, Sergei Y; Franceschi, E; van den Bent, M; Sanson, M; Lassman, A B; Lombardi, G; Gomez, D; Strowd, R E; Sepulveda Sanchez, J M; McBain, C; Welsh, L; Lobbous, M; Dahlrot, R; Pineda, E; Larrieu, D; Pellerino, A; Narita, Y; Bagley, S; Oliveira, N; Guo, Y; Veronese, L; Viviers, L; Yogendran, L; Ahluwalia, M S
